Biotech4 hours ago
Gilead Sciences Advances Growth Strategy with Focus on HIV, Oncology, and Innovation
Gilead Sciences focuses on developing treatments for HIV, cancer, and inflammatory diseases, driven by blockbuster drugs like Biktarvy. Growth relies on innovation, patents, and acquisitions. While...